Smartgroup Corporation (ASX:SIQ) CEO to retire

18Nov

Smartgroup Corporation (ASX:SIQ) CEO to retire

 

Smartgroup Corporation (ASX:SIQ) CEO Deven Billimoria to retire at the end of February 2020.

 Mr Billimoria has been with the organisation for more than 19 years and began his role as CEO in 2002.

Chief Financial Officer, Tim Looi will be appointed to Chief Executive Officer and Smartgroup has commenced a search process for a new Chief Financial Officer.

Earlier in the year, Smartgroup’s shares fell to a 52 week low after Mr Billimoria offloaded a significant number of shares for personal reasons, receiving a total of $8.36 million for the sale.

Shares in Smartgroup Corporation (ASX:SIQ) are trading 15.4 per cent lower at $9.30.

Copyright 2019 – Finance News Network


Source: Finance News Network

Share this post

Related Posts

25Jul

Stocks of the Hour: Pure Resources, WhiteHawk, Latin Resources

25 Jul 2024 - A snapshot of the stocks on the move, featuring Pure Resources (ASX:PR1), WhiteHawk (ASX:WHK) and Latin Resources (ASX:LRS).

Read More
03Sep

Bendigo and Adelaide Bank appoints David Foster as a non-executive director

04 Sep 2019 - Bendigo and Adelaide Bank (ASX:BEN) has appointed David Foster as a non-executive director.

Read More
01Oct

Flight Centre (ASX:FLT) says international travel won’t recover for years

01 Oct 2020 - Flight Centre (ASX:FLT) founder and chief executive Graham Turner says although there has been consistent uplift in demand since April, widespread and ongoing travel restrictions continue to hamper a more meaningful industry-wide recovery.

Read More
11May

Stocks of the Hour: Macquarie Group, News Corp & Goodman Group

07 May 2021 - A recap of the companies grabbing headlines in the morning session, featuring Macquarie Group, News Corp & Goodman Group.

Read More
06May

Mesoblast (ASX:MSB) dose first COVID-19 patients in Phase 2/3 trial

06 May 2020 - Mesoblast (ASX:MSB) today announced that the first patients have been dosed in the 300-patient randomized placebo-controlled Phase 2/3 trial in the United States of Mesoblast’s remestemcel-L in COVID-19 infected patients.

Read More
16Apr

Stocks of the Hour: Mayne Pharma, Rio Tinto, Monadelphous Group & Mineral Resources

16 Apr 2021 - A snapshot of the companies making headlines at 11am: Mayne Pharma (ASX:MYX) , Rio Tinto (ASX:RIO) , Monadelphous Group (ASX:MND) & Mineral Resources (ASX:MIN).

Read More
23Mar

Sigma Healthcare (ASX:SIG) reports NPAT up 133.6%

23 Mar 2021 - Sigma Healthcare (ASX:SIG) report NPAT up 133.6 per cent to $29.1 million.

Read More
26Aug

Stocks of the Hour: A2 Milk, Qantas & Woolworths

26 Aug 2021 - A snapshot of the stocks on the move featuring the A2 Milk company’s (ASX:A2M), Qantas (ASX:QAN) and Woolworths (ASX:WOW).

Read More
21Oct

Stocks of the Hour: Yandal Resources, Vection Technologies, Unico Silver

21 Oct 2024 - A snapshot of the stocks on the move, featuring Yandal Resources (ASX:YRL), Vection Technologies (ASX:VR1, OTC:VCTNY) and Unico Silver (ASX:USL).

Read More
25May

Estia (ASX:EHE) says occupancy falls, costs expected to rise on the back of covid-19

25 May 2020 - Aged care operator Estia Health (ASX:EHE) says disruptions caused by COVID-19 has led to a fall in occupancy levels which will lead to higher ongoing costs.

Read More